Theranostics Market Research Report Information by Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Disorders, Immunological Disorders and others), Technology [Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Sequencing, Others], End User (Hospitals and Clinics, Diagnostic Laboratories, Others) and Region - Forecast till 2032

Table of Contents

Chapter 1 Report Prologue

Chapter 2 Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4 Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Detection Technique Trends & Assessment

Chapter 5 Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6 Global Theranostics Market, by Therapeutic Area

6.1 Introduction

6.2 Oncology

6.2.1 Breast Cancer

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.2 Colorectal Cancer

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.3 Lung Cancer

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.4 Cervical Cancer

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.5 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Cardiovascular Diseases

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Neurological Disorders

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5 Immunological Disorders

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7 Global Theranostics Market, by Technology

7.1 Introduction

7.2 Polymerase Chain Reaction (PCR)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Immunohistochemistry (IHC)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 In Situ Hybridization (ISH)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 Sequencing

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.6 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8 Global Theranostics Market, by End User

8.1 Introduction

8.2 Hospitals and Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Diagnostic Laboratories

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9 Global Theranostics Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 Latin America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Developments & Strategies

Chapter 11 Company Profiles

11.1 Thermo Fisher Scientific Inc.

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financial Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.1.6 Key Strategies

11.2 Beckman Coulter, Inc.

11.3 F. Hoffmann-La Roche Ltd

11.4 Focus Diagnostics

11.5 Illumina, Inc.

11.6 Agilent Technologies, Inc.

11.7 QIAGEN

11.8 Abbott Laboratories

11.9 Myriad Genetics, Inc.

11.10 Foundation Medicine, Inc.

11.11 AmeriPath, Inc.

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Theranostics Industry

Chapter 13 Appendix

LIST OF TABLES

Table 1 Global Theranostics Market Synopsis, 2020-2027

Table 2 Global Theranostics Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Theranostics Market, by Region, 2020-2027 (USD Million)

Table 4 Global Theranostics Market, by Therapeutic Area, 2020-2027 (USD Million)

Table 5 Global Theranostics Market, by Technology, 2020-2027 (USD Million)

Table 6 Global Theranostics Market, by End User, 2020-2027 (USD Million)

Table 7 North America: Theranostics Market, by Therapeutic Area, 2020-2027 (USD Million)

Table 8 North America: Theranostics Market, by Technology, 2020-2027 (USD Million)

Table 9 North America Theranostics Market, by End User, 2020-2027 (USD Million)

Table 10 US: Theranostics Market, by Therapeutic Area, 2020-2027 (USD Million)

Table 11 US: Theranostics Market, by Technology, 2020-2027 (USD Million)

Table 12 US Theranostics Market, by End User, 2020-2027 (USD Million)

Table 13 Canada: Theranostics Market, by Therapeutic Area, 2020-2027 (USD Million)

Table 14 Canada: Theranostics Market, by Technology, 2020-2027 (USD Million)

Table 15 Canada Theranostics Market, by End User, 2020-2027 (USD Million)

Table 16 Latin America: Theranostics Market, by Therapeutic Area, 2020-2027 (USD Million)

Table 17 Latin America: Theranostics Market, by Technology, 2020-2027 (USD Million)

Table 18 Latin America Theranostics Market, by End User, 2020-2027 (USD Million)

Table 19 Europe: Theranostics Market, by Therapeutic Area, 2020-2027 (USD Million)

Table 20 Europe: Theranostics Market, by Technology, 2020-2027 (USD Million)

Table 21 Europe Theranostics Market, by End User, 2020-2027 (USD Million)

Table 22 Western Europe: Theranostics Market, by Therapeutic Area, 2020-2027 (USD Million)

Table 23 Western Europe: Theranostics Market, by Technology, 2020-2027 (USD Million)

Table 24 Western Europe Theranostics Market, by End User, 2020-2027 (USD Million)

Table 25 Eastern Europe: Theranostics Market, by Therapeutic Area, 2020-2027 (USD Million)

Table 26 Eastern Europe: Theranostics Market, by Technology, 2020-2027 (USD Million)

Table 27 Eastern Europe Theranostics Market, by End User, 2020-2027 (USD Million)

Table 28 Asia-Pacific: Theranostics Market, by Therapeutic Area, 2020-2027 (USD Million)

Table 29 Asia-Pacific: Theranostics Market, by Technology, 2020-2027 (USD Million)

Table 30 Asia-Pacific Theranostics Market, by End User, 2020-2027 (USD Million)

Table 31 Middle East & Africa: Theranostics Market, by Therapeutic Area, 2020-2027 (USD Million)

Table 32 Middle East & Africa: Theranostics Market, by Technology, 2020-2027 (USD Million)

Table 33 Middle East & Africa Theranostics Market, by End User, 2020-2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Theranostics Market

Figure 3 Segmentation Market Dynamics for Global Theranostics Market

Figure 4 Global Theranostics Market Share, by Therapeutic Area, 2020

Figure 5 Global Theranostics Market Share, by Technology, 2020

Figure 6 Global Theranostics Market Share, by End User, 2020

Figure 7 Global Theranostics Market Share, by Region, 2020

Figure 8 North America: Theranostics Market Share, by Country, 2020

Figure 9 Europe: Theranostics Market Share, by Country, 2020

Figure 10 Asia-Pacific: Theranostics Market Share, by Country, 2020

Figure 11 Middle East & Africa: Theranostics Market Share, by Country, 2020

Figure 12 Global Theranostics Market: Company Share Analysis, 2020 (%)

Figure 13 Thermo Fisher Scientific Inc.: Key Financials

Figure 14 Thermo Fisher Scientific Inc.: Segmental Revenue

Figure 15 Thermo Fisher Scientific Inc.: Geographical Revenue

Figure 16 Beckman Coulter, Inc.: Key Financials

Figure 17 Beckman Coulter, Inc.: Segmental Revenue

Figure 18 Beckman Coulter, Inc.: Geographical Revenue

Figure 19 F. Hoffmann-La Roche Ltd: Key Financials

Figure 20 F. Hoffmann-La Roche Ltd: Segmental Revenue

Figure 21 F. Hoffmann-La Roche Ltd: Geographical Revenue

Figure 22 Focus Diagnostics: Key Financials

Figure 23 Focus Diagnostics: Segmental Revenue

Figure 24 Focus Diagnostics: Geographical Revenue

Figure 25 Illumina, Inc.: Key Financials

Figure 26 Illumina, Inc.: Segmental Revenue

Figure 27 Illumina, Inc.: Geographical Revenue

Figure 28 Agilent Technologies, Inc.: Key Financials

Figure 29 Agilent Technologies, Inc.: Segmental Revenue

Figure 30 Agilent Technologies, Inc.: Geographical Revenue

Figure 31 QIAGEN: Key Financials

Figure 32 QIAGEN: Segmental Revenue

Figure 33 QIAGEN: Geographical Revenue

Figure 34 Abbott Laboratories: Key Financials

Figure 35 Abbott Laboratories: Segmental Revenue

Figure 36 Abbott Laboratories: Geographical Revenue

Figure 37 Myriad Genetics, Inc.: Key Financials

Figure 38 Myriad Genetics, Inc.: Segmental Revenue

Figure 39 Myriad Genetics, Inc.: Geographical Revenue

Figure 40 Foundation Medicine, Inc.: Key Financials

Figure 41 Foundation Medicine, Inc.: Segmental Revenue

Figure 42 Foundation Medicine, Inc.: Geographical Revenue

Figure 43 AmeriPath, Inc.: Key Financials

Figure 44 AmeriPath, Inc.: Segmental Revenue

Figure 45 AmeriPath, Inc.: Geographical Revenue